SiRNA-targeted inhibition and down-regulation of KLF6-SV1 expression can lead to long-term silencing of tumor cells, thereby inhibiting tumor growth and obviously improving the prognosis of malignant tumor patients (DiFeo et al., 2009b). The gene discussed is KLF6; the disease is cancer.